 |
Celecoxib oral liquid suspension |
|---|---|
| Trade Name | Nu-Celecoxib |
| Orphan Indication | Pediatric juvenile idiopathic arthritis |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-05 00:00:00 |
| Sponsor | NuBioPharma, LLC;111 Dennis Drive, Suite 121;Sanford, North Carolina, 27330 |
